연구동향 분석

Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial

김범석 기연경 한상엽 강덕희 노정우 정경환 김근호 김양욱 2021년

논문상세정보
인용/피인용
' Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • AST-120
  • DW-7202
  • adherence
  • chronic kidney disease
  • preference
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
474 0

0.0%

' Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial' 의 참고문헌

  • Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate
    Levey AS [2006]
  • Therapeutic effects of longterm administration of an oral adsorbent in patients with chronic renal failure : two-year study
    Takahashi N [2005]
  • The protein metabolite hypothesis, a model for the progression of renal failure : an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients
    Niwa T [1997]
  • The effects of AST-120 on chronic kidney disease progression in the United States of America : a post hoc subgroup analysis of randomized controlled trials
    Schulman G [2016]
  • Sustained uremic toxin control improves renal and cardiovascular outcomes in patients with advanced renal dysfunction: post-hoc analysis of the Kremezin Study against renal disease progression in Korea
    차란희 [2017]
  • Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients
    Barreto FC [2009]
  • Role of uremic toxin indoxyl sulfate in the progression of cardiovascular disease
    Gao H [2017]
  • Role for"uremic toxin"in the progressive loss of intact nephrons in chronic renal failure
    Motojima M [1991]
  • Review on uremic toxins : classification, concentration, and interindividual variability
    Vanholder R [2003]
  • Protective effect of an oral adsorbent on renal function in chronic renal failure : determinants of its efficacy in diabetic nephropathy
    Sanaka T [2004]
  • Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function
    Shoji T [2007]
  • Progression of glomerular sclerosis in experimental uremic rats by administration of indole, a precursor of indoxyl sulfate
    Niwa T [1994]
  • Prevalence of Chronic Kidney Disease in Korea: the Korean National Health and Nutritional Examination Survey 2011-2013
    박지인 [2016]
  • Major changes and improvements of dialysis therapy in Korea: review of end-stage renal disease registry
    진동찬 [2015]
  • KDOQI Clinical Practice Guideline for Diabetes and CKD : 2012 Update
  • KDIGO 2012 Clinical Practice Guideline for the evaluation and management of chronic kidney disease
    Andrassy KM [2013]
  • Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress
    Yu M [2011]
  • Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis
    Niwa T [1994]
  • Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease
    Lin CJ [2012]
  • Implications of proteinuria : CKD progression and cardiovascular outcomes
    Sarnak MJ [2011]
  • Effects of oral adsorbent AST-120 on the progression of chronic renal failure : a randomized controlled study
    Owada A [1997]
  • Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
    Brenner BM [2001]
  • Effect of ramipril vs amlodipine on renal outcomes in hy-pertensive nephrosclerosis : a randomized controlled trial
    Agodoa LY [2001]
  • Effect of a carbonaceous oral adsorbent on the progression of CKD : a multicenter, randomized, controlled trial
    Akizawa T [2009]
  • Cost implications of caring for chronic kidney disease:are interventions cost-effective?
    Trivedi H [2010]
  • Cardiorenal syndrome : the emerging role of protein-bound uremic toxins
  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts : a collaborative meta-analysis
  • AST-120, an oral adsorbent, delays the initiation of dialysis in patients with chronic kidney diseases
    Ueda H [2007]
  • AST-120 for the management of progression of chronic kidney disease
    Schulman G [2014]
  • A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010
    Mills KT [2015]
  • A multicenter, randomized, double-blind, placebo-controlled, dose-ranging study of AST-120(Kremezin)in patients with moderate to severe CKD
    Schulman G [2006]